Biotech · Private company
Yuhan Corporation
Track this companyFree. Adds Yuhan Corporation to your Dealase workspace and tells you when its record changes.
Clinical trials32 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- YH32367Phase 2 · HER2-Positive Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- YH42946Phase 2 · NSCLC (Non-small Cell Lung Cancer)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946PHASE1_PHASE2 · RECRUITING · started Oct 2, 2024ClinicalTrials.gov NCT06616766 · fetched Nov 12, 2026
- Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid TumorPHASE1_PHASE2 · RECRUITING · started Aug 26, 2022ClinicalTrials.gov NCT05523947 · fetched Nov 12, 2026
- A Study of Lazertinib in Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Positive Advanced Non-Small Cell Lung Cancer (NSCLC)PHASE1_PHASE2 · COMPLETED · started Oct 16, 2019ClinicalTrials.gov NCT04075396 · fetched Nov 12, 2026